The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy
Source
Cancer Medicine - ISSN 2045-7634-12:17 (2023) p. 17901-17913
The evolution and prognostic role of tumour-infiltrating lymphocytes and peripheral blood-based biomarkers in inflammatory breast cancer patients treated with neoadjuvant chemotherapy
Source
Cancers - ISSN 2072-6694-13:18 (2021) p.
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
Source
Oncoimmunology - ISSN 2162-402X-10:1 (2021) p.
The immunologic aspects in hormone receptor positive breast cancer
Source
Cancer Treatment and Research Communications - ISSN 2468-2942-25 (2020) p.
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer
Source
The Breast - ISSN 0960-9776-53 (2020) p. 212-220